EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 343 filers reported holding EXELIXIS INC in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $796,000 | -16.7% | 44,990 | +0.5% | 0.02% | -17.4% |
| Q2 2019 | $956,000 | -2.8% | 44,748 | +8.2% | 0.02% | -8.0% |
| Q1 2019 | $984,000 | +36.7% | 41,338 | +12.9% | 0.02% | +25.0% |
| Q4 2018 | $720,000 | +19.0% | 36,608 | +7.1% | 0.02% | +42.9% |
| Q3 2018 | $605,000 | +85.6% | 34,166 | +154.2% | 0.01% | +55.6% |
| Q3 2017 | $326,000 | – | 13,442 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |